RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
RPTP was delisted on the 24th of October, 2016.
97 hedge funds and large institutions have $212M invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 31 increasing their positions, 34 reducing their positions, and 28 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
9% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 34
10% less funds holding
Funds holding: 108 → 97 (-11)
19% less capital invested
Capital invested by funds: $261M → $212M (-$49.6M)
39% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 28
80% less call options, than puts
Call options by funds: $1.22M | Put options by funds: $6.06M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
+$18.4M |
| 2 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
+$11M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.44M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.59M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$1.55M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$29.6M |
| 2 |
TCP
Tourbillon Capital Partners
New York
|
-$6.58M |
| 3 |
State Street
Boston,
Massachusetts
|
-$6.01M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$5.05M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.89M |
RPTP Hedge Fund Activity: Q1 2016 in Review
97 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q1 2016, worth a combined $212M — down 19% from $261M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of RPTP and 17 opened new positions — a net loss of 11 holders — while 34 trimmed existing stakes and 31 added.
The largest buyer was Broadfin Capital, adding an estimated $18.4M. The largest seller was Credit Suisse, exiting entirely with an estimated $29.6M sold.
- 97 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q1 2016, down from 108 in Q4 2015.
- Funds reported $212M of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q1 2016, down 19% quarter-over-quarter.
- 17 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q1 2016 and 28 closed out, a net change of -11 holders.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) buyer in Q1 2016 was Broadfin Capital, an estimated $18.4M added.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) seller in Q1 2016 was Credit Suisse, an estimated $29.6M sold.
Based on aggregated 13F filings for Q1 2016.